EUVIMEDEUVIMED entdecken
Crossref

Waiting Times in Prostate Cancer Diagnosis and Treatment: A Ten-Year Experience in A Nigerian Teaching Hospital

C. J. Okeke, E. A. Jeje, R. W. Ojewola, M. A. Ogunjimi, U. U. Ogbobe, A. O. Obi, R. N. Babalola

West Africa Journal of Medicine · 29.03.2024 · 41 (3) · 317-321

DOI: 10.55891/wajm.v41i3.850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift West Africa Journal of Medicine, online erschienen am 29.03.2024. Verfasst von C. J. Okeke und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prostate cancer is still the leading male cancer and the leading cause of cancer deaths in Nigeria, and other low- and middle-income countries (LMIC) in Sub-Saharan Africa. Early diagnosis is essential to ensuring prompt treatment and reducing morbidity and mortality. Reducing the waiting times for diagnosis and treatment is therefore important. Aims and objectives: To study prostate cancer management waiting times, to serve as a baseline in improving the quality of cancer care in the Nigerian populace. Patients and methods: This was a ten-year retrospective study of waiting times of all histologically-confirmed prostate cancer patients seen at Alex-Ekwueme Federal Teaching Hospital, Abakaliki, Ebonyi State, Nigeria. Statistical analysis was done SPSS version 26. A P-value less than 0.05 was considered statistically significant.

Results

A total of 189 patients presented with prostate cancer; however, 73 patients with complete data were analysed. The mean age of the patients was 71.48±8.16 years. The median duration of symptoms before presentation was 6 months. The mean total prostate-specific antigen was 82.08±54.9ng/mL. The mean duration between the first visit to the definitive diagnosis was 6.53±11.68 months with a median of 1 month. The median duration from visit to treatment was 3 months with a mean of 9.71±13.4 months. There were no associations between occupation, highest educational level, financial constraints, and the different waiting times studied (P>0.05).

Conclusion

The waiting times for prostate cancer management were unduly prolonged in this study; patient-related factors did not influence this wait.

Zitieren

APA

Okeke, C. J., Jeje, E. A., Ojewola, R. W., Ogunjimi, M. A., Ogbobe, U. U., Obi, A. O., & Babalola, R. N. (2024). Waiting Times in Prostate Cancer Diagnosis and Treatment: A Ten-Year Experience in A Nigerian Teaching Hospital. West Africa Journal of Medicine, 41(3), 317-321. https://doi.org/10.55891/wajm.v41i3.850

Vancouver

Okeke CJ, Jeje EA, Ojewola RW, Ogunjimi MA, Ogbobe UU, Obi AO, et al. Waiting Times in Prostate Cancer Diagnosis and Treatment: A Ten-Year Experience in A Nigerian Teaching Hospital. West Africa Journal of Medicine. 2024;41(3):317-321. doi:10.55891/wajm.v41i3.850

BibTeX
@article{Okeke2024,
  author = {Okeke, C. J. and Jeje, E. A. and Ojewola, R. W. and Ogunjimi, M. A. and Ogbobe, U. U. and Obi, A. O. and Babalola, R. N.},
  title = {Waiting Times in Prostate Cancer Diagnosis and Treatment: A Ten-Year Experience in A Nigerian Teaching Hospital},
  journal = {West Africa Journal of Medicine},
  year = {2024},
  volume = {41},
  number = {3},
  pages = {317--321},
  doi = {10.55891/wajm.v41i3.850}
}
Kostenlos starten →